Welsis Stock Price, News & Analysis
Company Description
Welsis (OTC Link: WLSS) is a publicly traded health information services company in the Healthcare sector. The company has a market capitalization of $9.6M.
WLSS stock has gained 60.3% over the past year. Shares last traded at $4.60.
On a trailing twelve-month basis, Welsis reported revenue of $0 with net income of -$61K and diluted earnings per share of $-0.02.
This page provides a comprehensive overview of WLSS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Welsis (WLSS) stock last traded at $4.60. Over the past 12 months, the stock has gained 60.3%. At a market capitalization of $9.6M, WLSS is classified as a micro-cap stock with approximately 2.8M shares outstanding.
Latest News
SEC Filings
Welsis has filed 3 recent SEC filings, including 1 Form 10-Q, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on February 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all WLSS SEC filings →
Financial Highlights
operating income reached -$51K, and net income was -$61K. Diluted earnings per share stood at $-0.02. The company generated -$50K in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Welsis (WLSS) currently stands at 36 shares, up 100.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 51.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Welsis (WLSS) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
WLSS Company Profile & Sector Positioning
Welsis (WLSS) operates in the Health Information Services industry within the broader Healthcare sector and is listed on the OTC Link.